Skip to main content

Month: June 2020

Generation Mining Restarts the Environmental Assessment and Regulatory Review Process

TORONTO, June 11, 2020 (GLOBE NEWSWIRE) — Generation Mining Limited (CSE:GENM) (“Gen Mining”, “Generation”, or the “Company”) is pleased to announce the Company has restarted the Environment Assessment (EA) review and approval process for the Marathon Project with the Federal and Provincial Government Agencies.  This is being done in parallel with the initiation of a feasibility study.Jamie Levy, President and Chief Executive Officer of Generation Mining, commented: “We are very fortunate that the previous operators spent significant time effort and money on previous environmental studies and developing working relationships with the various governmental agencies.  This previous investment should help us in reducing time and money for our shareholders and ensure appropriate consultation with communities of interest.  Initial meetings...

Continue reading

SRG Mining Signs Additional Offtake Agreement Bringing Total Sales to 90% of Production

Montreal Quebec, June 11, 2020 (GLOBE NEWSWIRE) — Montreal, Quebec, June 11th, 2020 – SRG Mining Inc. (TSXV: SRG) (“SRG” or the “Company”) today provides an update on recent activities related to its Lola graphite project (the “Project”).The Company has recently signed its 6th offtake agreement for 8,000 tonnes over a three-year period. This brings the total signed off-take agreements to 136,000t over three years. These agreements represent approximately 90% of the Company’s anticipated production over that period. Our clients operate in various markets including refractories, expandable graphite and battery anode material. We remain actively engaged with several potential clients to continue to sign off-take agreements for our graphite production.The Company continues to believe in signing sales agreements for the anticipated production...

Continue reading

The Children’s Place Reports First Quarter 2020 Results

Reports Q1 GAAP Loss per Diluted Share of ($7.86) versus $0.28 in Q1 2019Reports Q1 Adjusted Loss per Diluted Share of ($1.96) versus $0.36 in Q1 2019Targets 300 Additional Store Closures; 200 in Fiscal 2020; 100 in Fiscal 2021SECAUCUS, N.J., June 11, 2020 (GLOBE NEWSWIRE) — The Children’s Place, Inc. (Nasdaq: PLCE), the largest pure-play children’s specialty apparel retailer in North America, today announced financial results for the first quarter ended May 2, 2020.Jane Elfers, President and Chief Executive Officer, said, “Although we are facing a period of uncertainty regarding the future impact of the COVID-19 pandemic, The Children’s Place is moving swiftly and decisively to proactively address these challenges. In an effort to structurally position the company for continued success, we are significantly accelerating our fleet...

Continue reading

AMAG Pharmaceuticals Announces Leadership Changes

Company initiates CFO & COO succession plan; appoints internal seasoned finance leader as interim CFOAnthony Casciano assumes expanded role as AMAG’s COOWALTHAM, Mass., June 11, 2020 (GLOBE NEWSWIRE) — AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that Edward (Ted) Myles, Chief Financial and Chief Operating Officer, is leaving the Company. Brian Piekos, Senior Vice President of Finance, has been appointed interim Chief Financial Officer and will become a member of the company’s Executive Leadership Team. Anthony (Tony) Casciano has been appointed Chief Operating Officer and will add significant operational responsibilities to his role in addition to leading commercial operations. Both appointments are effective immediately.“Our key priorities are to grow our core business, advance our pipeline and unlock shareholder...

Continue reading

Akoustis Signs Strategic Purchase Agreement with New Tier-1 OEM for WiFi 6E

– Includes Development of Multiple XBAW RF Filters for Multi-Band MU-MIMO Architectures –– Next Generation Filters Target Newly Approved 6 GHz Unlicensed Spectrum for High-Speed Enterprise WiFi 6E Applications –– Company Expects Delivery of First Samples by December 2020 –Charlotte, N.C., June 11, 2020 (GLOBE NEWSWIRE) — Akoustis Technologies, Inc. (NASDAQ: AKTS) (“Akoustis” or the “Company”), an integrated device manufacturer (IDM) of patented bulk acoustic wave (BAW) high-band RF filters for mobile and other wireless applications, announced today that it has signed a strategic purchase agreement with a new tier-1 enterprise WiFi OEM customer for multiple, new WiFi 6E XBAWTM filters operating above 5 GHz.The new filters will operate within the existing 5 GHz unlicensed spectrum as well as the 5.9-7.1 GHz bands recently approved...

Continue reading

Arvinas Appoints Linda Bain to its Board of Directors

NEW HAVEN, Conn., June 11, 2020 (GLOBE NEWSWIRE) — Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that Linda Bain has joined its Board of Directors. Ms. Bain, who is currently the Chief Financial Officer of Codiak BioSciences, Inc., is an experienced business and financial leader with a strong track record of driving results, accelerating growth, and building shareholder value.  “Linda is an excellent addition to Arvinas’ Board of Directors and her deep operational expertise will be highly valuable as Arvinas continues to grow,” said John Houston, Ph.D., President and Chief Executive Officer at Arvinas. “Linda’s experience in biotech will be a tremendous asset as we progress our trials and execute our strategic plan.”Ms. Bain...

Continue reading

BioXcel Therapeutics Announces First Patient Enrolled in Phase 1b/2 RELEASE Trial of BXCL501 for the Treatment of Opioid Withdrawal Symptoms

NEW HAVEN, Conn., June 11, 2020 (GLOBE NEWSWIRE) — BioXcel Therapeutics, Inc. (“BTI” or “Company”) (Nasdaq: BTAI), a clinical-stage biopharmaceutical company utilizing artificial intelligence to identify improved therapies in neuroscience and immuno-oncology, today announced that the first patient has been enrolled in the Phase 1b/2 RELEASE trial of BXCL501, the Company’s proprietary sublingual thin-film formulation of dexmedetomidine (“Dex”), for the treatment of opioid withdrawal symptoms.“The initiation of the RELEASE trial is a major milestone for our neuroscience program, as we believe it not only showcases BXCL501’s promise across multiple indications, but also supports this candidate’s potential as a sub-chronic treatment,” commented Vimal Mehta, Ph.D., Chief Executive Officer of BTI. “As the leading cause of death in the...

Continue reading

HC2 Holdings Announces Executive Management Change

NEW YORK, June 11, 2020 (GLOBE NEWSWIRE) — HC2 Holdings, Inc. (“HC2” or the “Company”) (NYSE: HCHC), a diversified holding company, announced today its Board of Directors has appointed Wayne Barr, Jr. as interim Chief Executive Officer. Mr. Barr succeeds Philip A. Falcone, effective immediately. The Board of Directors intends to commence a search for a permanent CEO and has formed a search committee comprised of Chairman Avie Glazer, and directors Warren Gfeller and Michael Gorzynski. “After a thorough review, the new HC2 Board has determined that the best course of action is to appoint Wayne as interim CEO while we embark on a search for a permanent successor,” said Mr. Glazer, Chairman of the Board of Directors of HC2. “With Wayne’s extensive financial and strategic experience, his familiarity with HC2 since its inception, along...

Continue reading

Affimed Announces Appointment of Angus Smith as Chief Financial Officer

 Mr. Smith brings broad financial management and US capital markets expertiseHeidelberg, Germany, June 11, 2020 – Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, today announced the appointment of Angus Smith as Chief Financial Officer, completing Affimed’s leadership team. Mr. Smith will begin his employment on July 13, 2020 and will be based out of Affimed’s New York office.Mr. Smith has broad biopharmaceutical industry experience including financial strategy, capital markets, business development and operations. He joins Affimed from Rockwell Medical, Inc., where he served as Chief Financial Officer.“We are pleased to welcome Mr. Smith who adds extensive US capital markets expertise,” said Dr. Adi Hoess, Affimed’s CEO. “His biopharmaceutical...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.